Aster DM makes a tepid debut; lists at 4% discount to issue price
Aster DM Healthcare on Monday made a tepid debut on the bourses, with the stock listing at Rs 182.10 on the BSE, a discount of 4.16 per cent against its issue price of Rs 190.
The stock slipped as much as 7 per cent to Rs 176.45 against its issue price.
The issue, which opened for subscription between February 12 to February 15, had received bids for 4,88,17,782 shares (1.31 times) against 3,73,70,415 offered by the company.
The portion reserved for institutional investors was subscribed 2.14 times, non-institutional category 58 per cent and retail investors witnessed a subscription of 1.19 times.
The company had raised Rs 294 crore from anchor investors.
Proceeds of the issue would be used towards repayment of debt, purchase of medical equipment, and for other general corporate purposes.
Kotak Mahindra Capital Company, Axis Capital and Goldman Sachs (India) Securities, ICICI Securities, JM Financial and YES Securities managed the company's public issue.
Aster operates in India, the Philippines, Jordan and all the GCC (Gulf Cooperation Council) states comprising the United Arab Emirates, Oman, Saudi Arabia, Qatar, Kuwait and Bahrain.